Skip to main content

Erika D. Feller, MD

Academic Title:

Assistant Professor

Primary Appointment:

Medicine

Location:

UMMC, S3B06

Phone (Primary):

(410) 328-5446

Fax:

(410) 328-3530

Education and Training

  • BA, History, Johns Hopkins University, Baltimore, MD
  • Post-baccalaureate, Pre-med, Columbia University, New York, NY
  • MD, University of Maryland School of Medicine, Baltimore, MD
  • Internship and Residency, Temple University Hospital, Philadelphia, PA
  • Fellowship, Cardiology, Temple University Hospital, Philadelphia, PA

Research/Clinical Keywords

Research Interests: Dr. Feller has participated in numerous clinical studies of both medical and surgical treatments for patients with congestive heart failure (CHF). Clinical Specialty: Congestive Heart Failure Cardiac Transplantation

Highlighted Publications

Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential.

Mondal NK, Sorensen EN, Feller ED, Pham SM, Griffith BP, Wu ZJ.

J Card Fail. 2015 Jul;21(7):564-71. doi: 10.1016/j.cardfail.2015.04.007. Epub 2015 Apr 25.

2.

Comparison of intraplatelet reactive oxygen species, mitochondrial damage, and platelet apoptosis after implantation of three continuous flow left ventricular assist devices: HeartMate II, Jarvik 2000, and HeartWare.

Mondal NK, Sorensen EN, Feller ED, Pham SM, Griffith BP, Wu ZJ.

ASAIO J. 2015 May-Jun;61(3):244-52. doi: 10.1097/MAT.0000000000000208.

PMID:
 
25757140
3.

Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.

Mondal NK, Sorensen EN, Hiivala NJ, Feller ED, Pham SM, Griffith BP, Wu ZJ.

Platelets. 2015;26(6):536-44. doi: 10.3109/09537104.2014.948840. Epub 2014 Aug 28.

PMID:
 
25167344
4.

FDG PET/CT imaging for LVAD associated infections.

Kim J, Feller ED, Chen W, Dilsizian V.

JACC Cardiovasc Imaging. 2014 Aug;7(8):839-42. doi: 10.1016/j.jcmg.2014.04.013. No abstract available.

PMID:
 
25124016
 Free Article
5.

University of Maryland surgical experience with the Jarvik 2000 axial flow ventricular assist device.

Sorensen EN, Pierson RN 3rd, Feller ED, Griffith BP.

Ann Thorac Surg. 2012 Jan;93(1):133-40. doi: 10.1016/j.athoracsur.2011.09.021. Epub 2011 Nov 23.

PMID:
 
22112796

Additional Publication Citations

Capsule endoscopy is safe in patients with pulsatile Novacor PC left ventricular assist device.

Fenkel JM, Grasso MA, Goldberg EM, Feller ED.

Gastrointest Endosc. 2007 Mar;65(3):559-60; author reply 560. No abstract available.

PMID:
 
17321277
7.

Twinrix vaccination schedules among injecting drug users.

Brim N, Zaller N, Taylor LE, Feller E.

Expert Opin Biol Ther. 2007 Mar;7(3):379-89.

PMID:
 
17309329
8.

Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.

Feller ED, Sorensen EN, Haddad M, Pierson RN 3rd, Johnson FL, Brown JM, Griffith BP.

Ann Thorac Surg. 2007 Mar;83(3):1082-8.

PMID:
 
17307463
9.

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA; UNLOAD Trial Investigators.

J Am Coll Cardiol. 2007 Feb 13;49(6):675-83. Epub 2007 Jan 26. Erratum in: J Am Coll Cardiol. 2007 Mar 13;49(10):1136.

PMID:
 
17291932
 Free Article
10.

Acute congestive heart failure in the emergency department.

Rogers RL, Feller ED, Gottlieb SS.

Cardiol Clin. 2006 Feb;24(1):115-23, vii. Review.

PMID:
 
16326261
11.

Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy.

Autieri MV, Kelemen S, Thomas BA, Feller ED, Goldman BI, Eisen HJ.

Circulation. 2002 Oct 22;106(17):2218-23.

PMID:
 
12390951
 Free Article
12.

Research Interests

 These include the Blood Volume Analyzer Feasibility Study; Randomized Evaluation of the Novacor LVAS in a Non-Transplant Population (RELIANT); Multicenter Pivotal Study of the Jarvik 2000; Evaluation of Ventrassist LVAS as Bridge to Cardiac Transplant; National Heart, Lung, and Blood Institute’s Heart Failure: HF-ACTION; Clinical Evaluation of the HeartMate II LVAS Pivotal Study; evaluation of ultrafiltration versus IV diuretics for patients hospitalized for acute decompensated CHF; evaluation of the pharmacokinetic and hemodynamic effects of carperitide in subjects with CHF; evaluation of the efficacy, safety, and tolerability of MCC-135 comparing QD vs BID doses in subjects with NYHA class II/III CHF; evaluation of the effects of KW-3902, both as monotherapy and in combination with furosemide on diuresis and renal function in patients with CHF and renal impairment treated with oral loop diuretics who require hospitalization for fluid overload.